|
시장보고서
U.S. Glaucoma Pharmaceuticals Market
|
Abstract
This research service explores the market for prescription ophthalmics used
for the treatment of glaucoma in the United States of America. It analyzes the
various challenges faced by pharmaceutical and biotech companies, and the
competitive advantages and disadvantages of their products in the market.
Table of Contents
1. EXECUTIVE SUMMARY
Executive Summary
2. U.S. GLAUCOMA PHARMACEUTICALS MARKET
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Introduction
- Disease Overview
Patient Forecasts
- Ocular Hypertension
- Open-Angle Glaucoma
Market Trends
- Industry Challenges and Strategies
- Market Drivers
3. PRODUCT AND PIPELINE ANALYSIS
Approved Therapies and Treatment Overview
- Treatment Overview
- Prostaglandin Analogues
- Beta-Blockers
- Combination Therapies
- Carbonic Anhydrase Inhibitors
- Alpha Adrenergic Agonists
Pipeline Analysis
4. COMPETITIVE ANALYSIS
Introduction
- Market Engineering Measurements
- Price Trends
- Competitive Structure
Market Share and Revenue Forecasts
- Market Share
- Revenue Forecast
5. APPENDIX
Decision Support Databases
- Total Population
- Population Aged 65 and Up
- Glaucoma Prevalence
- Glaucoma Incidence
- Glaucoma Drugs in Clinical Trials
|
